A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis
A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis
The purpose of this study is to asses the efficacy, safety and tolerability of repeat doses of IRL201104 in Adult Participants with Active Eosinophilic Esophagitis (EoE)
Study Type: Interventional (Clinical Trial)
Estimated Enrollment: 36 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Phase 2a, Double-blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy, Safety, and Tolerability of IRL201104 in Adult Participants With Active Eosinophilic Esophagitis (EoE)
Estimated Study Start Date: November 30, 2021
Estimated Primary Completion Date: September 2022
Estimated Study Completion Date: September 2022
Arm:
- Experimental: Arm 1: IRL201104 Dose A
- Experimental: Arm 2: IRL201104 Dose B
- Placebo Comparator: Arm 3: Placebo
| Category | Value |
|---|---|
| Study type(s) | Interventional |
| Estimated enrolment | 36 |
| Estimated Study start date | 30 November 2021 |
| Estimated Study Completion Date | 01 September 2022 |